← Open Payments lookup

SARAH WEATHERFORD: Open Payments

NPI 1255987699 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,043 in 116 payments from 14 companies in 2025. Trend: 2023 $840 · 2024 $2,095 · 2025 $2,043

Food & beverage: $2,043
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)37$447
ABBVIE INC.21$351
Vanda Pharmaceuticals Inc.14$278
Neurocrine BioSciences, Inc.10$219
Axsome Therapeutics, Inc.3$139
Supernus Pharmaceuticals, Inc.1$119
Corium, LLC9$95
Teva Pharmaceuticals USA, Inc.4$85
Lundbeck LLC4$74
Otsuka America Pharmaceutical, Inc.4$68

Products named: CAPLYTA, VRAYLAR, INGREZZA, FANAPT, Auvelity, REXULTI, Qelbree, Azstarys.

Industry payments across AR — which companies pay providers there.